Rapid disappearance of AMLI/ETO fusion transcripts in patients with t(8;21) acute myeloid leukemia following bone marrow transplantation and chemotherapy

References

• Borrow H., Goddard A. D., Sheer D., Solomon E. Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17. Science 1990; 249: 1577–1580
   PubMed Web of Science ®Google Scholar
• Chang K. S., Fan Y. H., Stass S. A., Estey E. H., Wang G., Trujillo J. M., Erickson P., Drabkin H. A. Expression of AMLI-ETO fusion transcripts and detection of minimal residual disease in t(8;21)-positive acute myeloid leukemia. Oncogene 1993; 8: 983–988
   PubMed Web of Science ®Google Scholar
• Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem 1987; 162: 156–-159
   PubMed Web of Science ®Google Scholar
• De The H., Chomienne C., Lanotte M., Degos L., Dejean A. The t(15;17) translocation of acute promyelocytic leukemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus. Nature 1990; 347: 558–561
   PubMed Web of Science ®Google Scholar
• Diverio D., Pandolfi P. P., Biondi A., Avvisati G., Peti M. C., Mandelli F., Pelicci P. G., Coco F. Absence of reverse transcription-polymerase chain reaction detectable residual disease in patients with acute promyelocytic leukemia in long-term remission. Blood 1993; 82: 3556–3559
   PubMed Web of Science ®Google Scholar
• Downing J. R., Head D. R., Curcio-Brint A. M., Husshof M. G., Motroni T. A., Raimondi S. C., Carroll A. J., Drabkin H. A., Wilman C., Theil K. S., Civin C. I., Erickson P. An AMLI/ETO fusion transcript is consistently detected by RNA-based polymerase chain reaction in acute myelogenous leukemia containing the (8;21)(q22;q22) translocation. Blood 1993; 81: 2860–2865
   PubMed Web of Science ®Google Scholar
• Erickson P., Gao J., Chang K. S., Look T., Whisenant E., Raimondi S., Lasher R., Trujillo J. M., Rowley J., Drabkin H. Identification of breakpoint in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AMLI/ETO, with similarity to Drosophila Segmentation gene, runt. Blood 1992; 80: 1825–1831
   PubMed Web of Science ®Google Scholar
• Kamps M. P., Murre C., Sun X. H., Baltimore D. A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in pre-B ALL. Cell 1990; 60: 547–555
   PubMed Web of Science ®Google Scholar
• Kitchingman G. Residual disease detection in multiple follow-up samples in children with acute lymphoblastic leukemia. Leukemia 1994; 8: 395–401
   PubMed Web of Science ®Google Scholar
• Kozu T., Miyoshi H., Shimizu K., Maseki N., Kaneko Y., Asou H., Kamada N., Ohki M. Junctions of the AML1/MTG8(ETO) fusion are constant in t(8:21) acute myeloid leukemia detected by reverse transcription polymerase chain reaction. Blood 1993; 82: 1270–1276
   PubMed Web of Science ®Google Scholar
• Kusec R., Laczika K., Knobl P., Friedl J., Greinix H., Kahls P., Linkesch W., Schwarzinger I., Miterbauer G., Purtscher B., Haas O. A., Lehner K., Jaeger U. AMLI/ETO fusion mRNA can be detected in remission blood samples of all patient with t(8;21) acute myeloid leukemia after chemotherapy or autologous bone marrow transplantation. Leukemia 1994; 8: 735–739
   PubMed Web of Science ®Google Scholar
• Laczika K., Mitterbauer G., Korninger L., Knobl P., Schwarzinger I., Kapiotis S., Haas O. A., Kyrie P. A., Pont J., Oehler L., Purtscher B., Thalhammer F., Lechner K., Jaeger U. Rapid achievement of PML-RARa polymerase chain reaction (PCR)-negativity by combined treatment with all-trans-retinoic acid and chemotherapy in acute promyelocytic leukemia; a pilot study. Leukemia 1994; 8: 1–5
   PubMed Web of Science ®Google Scholar
• Lee M., Khouri I., Champlin R., Kantarjian H., Talpaz M., Tujillo J., Freireich E., Deisseroth A., Stass S. Detection of minimal residual disease by polymerase chain reaction of bcr/abl transcripts in chronic myelogenous leukemia follows allogeneic bone marrow transplantation. Br. J. Hematol 1992; 82: 708–714
   PubMed Web of Science ®Google Scholar
• Mallentin J. D., Murre C., Donlon T. A., McCaw P. S., Smith S. D., Carroll A. J., McDonald M. E., Baltimore D., Cleary M. L. The gene for enhancer binding proteins E12/E47 lies at the t(1;19) breakpoint in acute leukemias. Science 1989; 246: 379–382
   PubMed Web of Science ®Google Scholar
• Maruyama F., Stass S. A., Estey E. H., Cork A., Hirano M., Ino T., Freireich E. J., Yang P., Chang K. S. Detection of AMLI/ETO fusion transcript as a tool for diagnosing t(8:21) positive acute myelogenous leukemia. Leukemia 1994; 8: 40–45
   PubMed Web of Science ®Google Scholar
• Maseki N., Miyoshi H., Shimizu K., Homma C., Ohki M., Sakurai M., Kaneko Y. The 8:21 chromosome translocation in acute myeloid leukemia is always detectable by molecular analysis using. AMLI, Blood 1993; 81: 1573–1579
   PubMed Web of Science ®Google Scholar
• Miyamura K., Tahara T., Tanimoto M., Morishita Y., Kawashima K., Morishima Y., Saito H., Tsuzuki S., Takeyama K., Kodera Y., Matsuyama K., Hirabayashi N., Yamada H., Naito K., Imai K., Sakamaki H., Asai O., Mizutani S. Long persistent bcr-abl positive transcript detected by polymerase chain reaction after marrow transplant for chronic myelogenous leukemia without clinical relapse: A study of 64 patients. Blood 1993; 81: 1089–1093
   PubMed Web of Science ®Google Scholar
• Miyoshi H., Shimizu K., Kozu T., Maseki N., Kaneko Y., Ohki M. t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia ara clustered within a limited region of a single gene. AMLI, Proc. Natl. Acad. Sci. USA 1991; 88: 10431–10434
   PubMed Web of Science ®Google Scholar
• Nakajima-Lijima S., Hamada H., Reddy P., Kakunaga T. Molecular structure of the human cytoplasmic b-actin gene: Interspecies homology of sequence in the intros. Proc. Natl. Acad. Sci. USA 1985; 82: 6133–6137
   PubMed Web of Science ®Google Scholar
• Nucifora G., Birn D. J., Erickson P., Gao J., LeBeau M. M., Drabkin H. A., Rowley D. Detection of DNA rearrangement in the AMLI and ETO loci and of an AMLI/ETO fusion mRNA in patients with t(8;21) acute myeloid leukemia. Blood 1993; 81: 883–888
   PubMed Web of Science ®Google Scholar
• Nucifora G., Larson R. A., Rowley J. D. Persistence of the 8;21 translocation in patients with acute myeloid leukemia type M2 in long-term remission. Blood 1993; 82: 712–715
   PubMed Web of Science ®Google Scholar
• Privitera E., Lucicano A., Ronchetti D., Alico M., Santostasi T., Basso G., Biondi A. Molecular variants of the 1;19 chromosomal translocation in pediatric acute lymphoblastic leukemia (ALL). Leukemia 1994; 8: 554–559
   PubMed Web of Science ®Google Scholar
• Sakata N., Hara J., Osugi Y., Kurahashi H., Inoue M., Yumura-Yagi K., Tawa A., Kawa-Ha K. Genotypic typing using amplified variable number of tandem repeats with polymerase chain reaction following allogeneic bone marrow transplntation. Jpn. J. Pediatr. Hematol 1992; 6: 468–472
   Google Scholar
• Satake N., Maseki N., Kozu T., Sakashita A., Kobayashi H., Sakurai M., Ohki M., Kaneko Y. Disappearance of AML1-MTG8 (ETO) fusion transcript in acute myeloid leukemia patients with t(8;21) in long-term remission. Br. J. Haematol 1995; 91: 892–898
   PubMed Web of Science ®Google Scholar
• Shimizu K., Miyoshi H., Kozu T., Nagata J., Enomoto K., Maseki N., Kaneko Y. Consistent disruption of the AMLI gene occurs within a single intron in the (8;21) chromosomal translocation. Cancer Research 1992; 52: 6945–6948
   PubMed Web of Science ®Google Scholar
• Swirsky D. M., Li Y. S., Matthews J. G., Flemans R. J., Rees J. K. H., Hayhoe F. G.J. 8;21 translocation in acute granulocytic leukaemia: Cytological, cytochemical and clinical features. Br. J. Haematol 1984; 56: 199
   PubMed Web of Science ®Google Scholar
• Zahng T., Hillion J., Tong J. H., Cao Q., Chen S. J., Berger R., Chen Z. AML-1 gene rearrangement and AMLI-ETO gene expression as molecular markers of acute myeloblastic leukemia with t(8;21). Leukemia 1994; 8: 729–734
   PubMed Web of Science ®Google Scholar